Licensed Test definition

Licensed Test means any process or use thereof (a) which is covered by an unexpired claim contained in the Patent Rights in the country in which the Licensed Test is made, used, sold or transferred; or (b) the use of which is covered in an unexpired claim contained in the Patent Rights in the country in which the Licensed Test is made, used, sold or transferred.
Sample 1Sample 2Sample 3
Licensed Test means the performance of a Licensed PCR Test or a Licensed Expanded PCR Test by IGEN or its Affiliates in the Plasma Testing Field for the purpose of determining nucleic acid sequences of any one analyte in a Test Sample. Multiple performance of a Licensed Test for any one analyte at any one point in time in any one Test Sample, for reproducibility, shall be considered as one Licensed Test. Performance of a multiplex PCR test shall be treated as multiple Licensed Tests; e.g., one Licensed Test for each analyte targeted by the multiplex PCR test. See examples provided in Section 4.5B.
Sample 1
Licensed Test means the use of tumor antigens to detect autoantibodies in a sample to indicate the presence of lung cancer and shall include the Oncimmune Developed Improvements and the HDL Developed Improvements, in both cases developed or created during the Term.
Sample 1

Examples of Licensed Test in a sentence

  • For clarity, the foregoing license excludes the sale or other disposition of any Licensed Test for performance in any location other than a qualified laboratory operated by Avatao, or, subject to Section 2.2, an Avatao Affiliate.

  • Commencing as of the date of First Commercial Sale of the first Licensed Test hereunder, Avatao and its Affiliates shall keep for at least live (5) years from the end of the Calendar Year to which they pertain complete and accurate records of (i) sales by Avatao and its Affiliates, as the case may be, of each Licensed Test, and (ii) the achievement of milestones hereunder, in each case in sufficient detail to allow the accuracy of the payments hereunder and achievement of milestones to be confirmed.

  • Additionally, the final rulerequires that such results be considered prior to release of units quarantined in a ‘‘lookback’’ procedure.In particular, FDA recommends that blood establishments voluntarily initiate ‘‘lookback’’ procedures based on HIVantigen testing, as indicated in theAugust 8, 1995, Memorandum to All Registered Blood Establishments,Regarding Recommendations for Donor Screening with a Licensed Test for HIV- 1 Antigen.

  • Sublicensee must pay running royalties for the rights granted to Sublicensee under this Agreement in connection with the Sale of each Licensed Test by or for the benefit of Sublicensee, at royalty rates that shall be set forth in a royalty rate agreement among the Parties.

  • Avatao shall not offer for sale or sell, and shall not permit its Affiliates to offer for sale or sell, any Licensed Test prior to having obtained all required Regulatory Approvals in the Territory.

  • Burning Rock shall not export or exploit the Licensed Test, Know-How or Marks to countries and regions outside of the PRC Territory.

  • For example, if LICENSEE recovers $500,000 concerning a Licensed Test and incurs $250,000 in legal fees, costs and expenses, LICENSEE will pay LICENSOR $125,000.

  • This Agreement shall commence as of the Effective Date and, unless terminated early in accordance with this Article 9, shall continue in full force and effect, on a Licensed Test-by-Licensed Test basis until the expiration of the Royalty Term for such Licensed Test.

  • Scope of Work includesSECTION 15030 MECHANICAL SYSTEMS TESTING AND BALANCING 1.01GENERAL The Licensed Test and Balance Contractor shall bid directly to the Owner to remain completely independent of the mechanical or general contractor.

  • If, at any time after the Effective Date, Avatao discovers that any Licensed Test or the use thereof in the Field or the practice of any Licensed Technology solely as permitted hereunder infringes claims of an unexpired patent or patents other than those in the Licensed Patent Rights, Avatao may, if it has not already done so, negotiate with the owner of such patents for a license on such terms as Avatao deems appropriate.


More Definitions of Licensed Test

Licensed Test means any gene-based treatment stratification test, product or method to identify patients with stage I and IIA NSCLC who may benefit from adjuvant chemotherapy that uses, is used in, or is made by practicing any process, art or method that, but for the sublicense rights granted in this Agreement, would infringe, or contribute to, or induce the infringement of, any Sublicensed Patent Rights or that use Know-How or is made by practicing any process, art of method incorporating, relating to or derived from Know-How. The Licensed Test is currently commercially available in the United States under OncoCyte’s brand name DetermaRx™. Licensed Test also includes every test, product or method made, used, offered for Sale, Sold, imported, exported or exploited using any of OncoCyte’s Marks.
Sample 1

Related to Licensed Test

  • Non-Microsoft Product means any third-party-branded software, data, service, website or product, unless incorporated by Microsoft in a Product.

  • Licensed System means, collectively:

  • Licensed Program means the executable processing programs of licensed information, which is composed of various modules in the Licensed Software package provided by the Licensor.

  • Licensed service area means the geographic area in which

  • Diagnostic Product means an assemblage of reagents, including but not limited to reagents packaged in the form of a kit, useful in performing a Licensed Service.

  • Licensed Product means any pharmaceutical product containing a Licensed Compound (alone or with other active ingredients), in all forms, presentations, formulations and dosage forms.

  • Hemp product means the same as that term is defined in § 3.2-4112.

  • Licensed Compound means a TAK-385 Licensed Compound or a TAK-448 Licensed Compound.

  • Collaboration Product means any pharmaceutical product in finished form that contains a Collaboration Compound, either as the sole active ingredient or in combination with one or more other active ingredients, and all present and future formulations, dosages and dosage forms thereof.

  • Collaboration Compound means any of the following: (a) FG-4592, (b) any HIF Compound (other than FG-4592) that is added to this Agreement pursuant to Section 3.6, and (c) any salts, esters, complexes, chelates, crystalline and amorphous morphic forms, pegylated forms, enantiomers (excluding regioisomers), prodrugs, solvates, metabolites and catabolites of any of the foregoing ((a) or (b)).

  • Phase I Trial means a clinical trial of a Licensed Product in human patients designated as a Phase I Trial and conducted primarily for the purpose of determining the safety of and/or the metabolism and pharmacologic actions of the Licensed Product in humans, as described under 21 CFR § 312.21(a) (as hereafter modified or amended) and any of its foreign equivalents. For purposes of this definition, Phase I Trial shall specifically exclude trials in healthy volunteers.

  • Genetic testing means an analysis of genetic markers to exclude or identify a man as the father or a woman as the mother of a child. The term includes an analysis of one or a combination of the following:

  • Licensed Service means performance of a service for any consideration using a Licensed Product, or the practice of a Licensed Process. For clarity, research and development of Licensed Products by Licensee, its Affiliates, or a Sublicensee does not constitute a Licensed Service.

  • Licensed Compounds means: (a) Research Program Active Compounds; (b) Novartis Active Compounds; (c) salts, hydrates, solvates, esters, metabolites, intermediates, stereoisomers and polymorphs of Research Program Active Compounds or Novartis Active Compounds; and (d) prodrugs of Research Program Active Compounds or Novartis Active Compounds (any of the foregoing, a “Licensed Compound”).

  • Phase I Clinical Study means a human clinical study of a product, the principal purpose of which is a preliminary determination of safety in healthy individuals or patients, as described in 21 C.F.R. 312.21(a).

  • Licensed producer means an agent, broker, or reinsurance intermediary licensed pursuant to the applicable provision of the insurance law of any jurisdiction.

  • Screening Test means a drug or alcohol test which uses a method of analysis allowed by the Minnesota Drug and Alcohol Testing in the Workplace Act to be used for such purposes.

  • Phase III Trial means a Clinical Trial of an investigational product in subjects that incorporates accepted endpoints for confirmation of statistical significance of efficacy and safety with the aim to generate data and results that can be submitted to obtain Regulatory Approval as described in 21 C.F.R. 312.21(c), or a comparable Clinical Trial prescribed by the relevant Regulatory Authority in a country other than the United States.

  • Genetic test means an analysis of human DNA, RNA, chromosomes, proteins, or metabolites, that detect genotypes, mutations, or chromosomal changes. The term “genetic test” does not mean an analysis of proteins or metabolites that does not detect genotypes, mutations, or chromosomal changes; or an analysis of proteins or metabolites that is directly related to a manifested disease, disorder, or pathological condition that could reasonably be detected by a health care professional with appropriate training and expertise in the field of medicine involved.

  • Phase I Study means a human clinical trial in any country that would satisfy the requirements of 21 C.F.R. § 312.21(a) (FDCA), as amended from time to time, and the foreign equivalent thereof.

  • MSAA Indicator Technical Specifications document means, as the context requires, either or both of the document entitled “Multi-Sector Service Accountability Agreement (MSAA) 2019-20 Indicator Technical Specifications November 5, 2018 Version 1.3” and the document entitled “Multi-Sector Service Accountability Agreement (MSAA) 2019-20 Target and Corridor-Setting Guidelines” as they may be amended or replaced from time to time;

  • Manufacturing Site means the facilities where a Compound is Manufactured by or on behalf of a Party, as such Manufacturing Site may change from time to time in accordance with Section 8.7.

  • Phase I Clinical Trial means a human clinical trial that is intended to initially evaluate the safety and/or pharmacological effect of a Product in subjects or that would otherwise satisfy requirements of 21 C.F.R. 312.21(a), or its foreign equivalent.

  • Phase 2 Clinical Trial means a human clinical trial of a product in any country that would satisfy the requirements of 21 C.F.R. 312.21(b) and is intended to explore a variety of doses, dose response, and duration of effect, and to generate initial evidence of clinical safety and activity in a target patient population, or a similar clinical study prescribed by the relevant Regulatory Authorities in a country other than the United States.

  • Biological Samples means any physical samples obtained from Study Participants in accordance with the Protocol for the purposes of the Study.

  • Product Candidate means each biological and drug candidate, compound or other device or product being developed, labeled, manufactured, marketed, sold and/or distributed by the Company or a Company Subsidiary, or regarding which the Company or a Company has rights, and including any such biological and drug candidate, compound or product that has received Marketing Approval.